Tag Archives: Michael Corbett

Treatment Research: Cortene’s InTime trial of CT38 results in sustained symptom improvement in ME/CFS

Acute Corticotropin-Releasing Factor Receptor Type 2 Agonism Results in Sustained Symptom Improvement in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, by Gerard Pereira, Hunter Gillies, Sanjay Chanda, Michael Corbett, Suzanne D. Vernon, Tina Milani and Lucinda Bateman in Front. Syst. Neurosci., 01 Sep … Continue reading

Posted in News | Tagged , , , , , , , , , , | Comments Off on Treatment Research: Cortene’s InTime trial of CT38 results in sustained symptom improvement in ME/CFS